Sun Pharmaceuticals, a Mumbai-based drug-maker, said it has increased its stake in Israel-based Taro Pharmaceutical Industries Ltd to 34.4 per cent. The private equity firm Brandes Investment Partners, which was opposing the Sun-Taro deal sold its 9.4 per cent cent stake and that now brings Sun Pharma's stake in Taro to more that one-third.
